Advertisement Jonathan S. Helfgott, FDA Compliance Officer for Center for Drug Evaluation & Research (CDER), to Address PHT Corporation U.S. PRO & eCOA Congress - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about

Jonathan S. Helfgott, FDA Compliance Officer for Center for Drug Evaluation & Research (CDER), to Address PHT Corporation U.S. PRO & eCOA Congress

Policy and compliance expert to discuss FDA perspective on compliant use of ePRO instruments

Mr. Helfgott specializes in Computerized Systems used in FDA regulated Clinical Investigations. Prior to joining CDER in 2010, he worked at the Center for Devices and Radiological Health (CDRH) within the Division of Bioresearch Monitoring (BIMO). Mr. Helfgott is also a Lecturer for Johns Hopkins University’s Graduate Program in Bioscience Regulatory Affairs. He is the Co-Editor of the Food and Drug Law Institute’s 2009 Publication, "Biomedical Software Regulation."

Mr. Helfgott has also been published in Peer Reviewed Journals such as Applied Clinical Trials, RAPS Focus, Association of Clinical Research Professionals, FDLI Update, Touch Briefings, and Medical Device and Diagnostic Industry. Mr. Helfgott has also lectured for organizations such as DIA, ACRP, RAPS, SOCRA, SCDM, AdvaMed, CHI, CBI, and FDA News as well as academic institutions such as Northwestern University, Columbia University, Johns Hopkins University, University of Colorado Denver Medical School, University of Pittsburgh Medical Center, Georgetown University, Stanford University School of Medicine, Children’s Hospital of Philadelphia, Shriners Hospitals, and NIH’s National Heart Lung and Blood Institute.

Mr. Helfgott co-developed the Software Education Program for the CDRH Staff College through the Medical Device Fellowship Program. Prior to joining FDA in May 2006, Mr. Helfgott conducted genetic research using micro-array technology at the NIH’s National Institute on Aging. Mr. Helfgott received his MS from Johns Hopkins University and his BS in Cell Biology and Molecular Genetics from the University of Maryland College Park.

The PRO & eCOA Congress Agenda features 20 new presentations, case studies, debates and roundtable discussions from professionals actively involved in eClinical research programs. Educational sessions are based on best practices and lessons learned, and provide actionable information attendees can implement at their organizations.

Space is limited. Register today for the 2013 Baltimore PRO & eCOA Congress

PHT invites all Congress alumni to join the exclusive PRO & eCOA Congress LinkedIn Community to exchange information, ideas and experiences throughout the year.